TY  - JOUR
AU  - Martin-Broto, Javier
AU  - Redondo, Andres
AU  - Moura, David S
AU  - Valverde, Claudia
AU  - Morales, Jose Manuel
AU  - Lopez-Pousa, Antonio
AU  - Martinez-Trufero, Javier
AU  - Gutierrez, Antonio
AU  - Díaz-Beveridge, Roberto
AU  - Luna, Pablo
AU  - Martinez-Marin, Virginia
AU  - Marcilla, David
AU  - Arribas, Ivan
AU  - Ledesma, Patricio
AU  - Lopez-Martin, Jose Antonio
AU  - Di Lernia, Davide
AU  - Zamora, Jorge
AU  - Hindi, Nadia
PY  - 2022
DO  - 10.1038/s41467-022-33975-6
UR  - http://hdl.handle.net/10668/19548
T2  - Nature communications
AB  - Desmoid fibromatosis (DF) are mesenchymal neoplasms, with potential aggressive course and relevant clinical impact. New systemic therapy modalities are needed in this symptomatic/progressive population. In this multicenter, phase II trial...
LA  - en
KW  - Humans
KW  - Fibromatosis, Aggressive
KW  - Paclitaxel
KW  - Albumins
KW  - Pain
TI  - A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.
TY  - research article
VL  - 13
ER  -